Collegium Pharmaceutical, Inc. COLL Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s change in AP?
- Collegium Pharmaceutical, Inc. (COLL) reported change in AP of -$3.83M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s change in AP changed year-over-year?
- Collegium Pharmaceutical, Inc.'s change in AP decreased by 127.5% year-over-year, from $13.92M to -$3.83M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s change in AP?
- Over 3 years (2021 to 2024), Collegium Pharmaceutical, Inc.'s change in AP has grown at a 26.2% compound annual growth rate (CAGR), from -$6.01M to -$12.09M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.